Medplus Health Services Limited — Important, 25-03-2025: General Updates

Optival Health Solutions, a subsidiary of MedPlus Health Services, has received suspension orders for drug licenses at two stores in Karnataka, lasting four days each. This action stems from violations under the Drugs and Cosmetics Act, which could result in an approximate revenue loss of ₹3.92 lakhs and ₹3.44 lakhs respectively. While these suspensions may cause short-term disruptions, the overall impact on MedPlus's operations may be manageable if resolved swiftly. The situation highlights potential risks to the company’s compliance and operational consistency, prompting investors to keep a close watch on how management addresses these issues.